Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

Schrodinger Inc (NASDAQ:SDGR)

• On Feb. 18, Schrödinger reported inducement grants under Nasdaq Listing Rule 5635(c)(4). The company's stock fell around 28% over the past month and has a 52-week low of $11.15.
• RSI Value: 29.9
• SDGR Price Action: Shares of Schrodinger rose 1.6% to close at $11.81 on Wednesday.
• Edge Stock Ratings: 2.78 Momentum score.

HealthStream Inc (NASDAQ:HSTM)      

• HealthStream said it will host a conference call and webcast to discuss its fourth quarter financial results on Tuesday, Feb. 24. The company's stock fell around 6% over the past month and has a 52-week low of $19.50.
• RSI Value: 29.9
• HSTM Price Action: Shares of HealthStream fell 1.4% to close at $20.00 on Wednesday.
• Benzinga Pro’s charting tool helped identify the trend in HSTM stock.

Genmab A/S – ADR (NASDAQ:GMAB)

• On Feb. 17, Genmab posted weaker-than-expected quarterly earnings. The company's stock fell around 7% over the past month and has a 52-week low of $17.24.
• RSI Value: 29.4
• GMAB Price Action: Shares of Genmab fell 2.8% to close at $29.16 on Wednesday.
• Benzinga Pro’s signals feature notified of a potential breakout in GMAB shares.

Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.

Photo via Shutterstock